Odile Blanchet

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years

Philippe Rousselot, Françoise Huguet, Delphine Réa et al. · Blood · 2006 · 530 citations

Pharmacy, Hematology, Pharmacotherapy +3

Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

Éric Jourdan, Nicolas Boissel, Sylvie Chevret et al. · Blood · 2013 · 357 citations

Medicine, Hematology, Oncology +16

Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients

Jérôme Tamburini, Caroline Elie, Valérie Bardet et al. · Blood · 2007 · 142 citations · Full text

Medicine, Hematology, Oncology +13

A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study

Patrice Chevallier, Myriam Labopin, Pascal Turlure et al. · Leukemia · 2011 · 123 citations

Medicine, Hematology, Oncology +13

PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study

J Familiadès, Marina Bousquet, Mårina Lafage‐Pochitaloff et al. · Leukemia · 2009 · 122 citations

Life Sciences, Genetics, Oncology +14